Until now, techniques such as siRNA, shRNA and microRNA-based gene silencing were utilized to generate COX-2 knockdown models in glioblastoma, breast cancer, bladder tumors and melanoma (Figure 1) [10,12,28,29,30,31,32]. The gene discussed is PTGS2; the disease is breast carcinoma.